TOWN:NASDAQTowne Bank Analysis
Data as of 2026-06-11 - not real-time
$35.04
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
TowneBank (TOWN) is trading at $35.04, roughly 12% below its DCF‑derived fair value of $45.56, suggesting a material upside opportunity. The stock sits above its 20‑day ($34.15), 50‑day ($34.74) and 200‑day ($34.56) simple moving averages, indicating short‑term price strength, while the MACD histogram is positive and the MACD line sits above the signal line, a bullish technical signal. RSI at 57.6 reinforces a neutral‑to‑slightly‑bullish stance without overbought pressure. Volume remains stable and the price is near the immediate resistance of $35.19, with support anchored at $33.10. Recent news confirms a 3.7% dividend increase to $0.28 per share, pushing the dividend yield to 3.11% and maintaining a payout ratio around 52%, underscoring dividend sustainability. Revenue has surged 36% year‑over‑year, and operating margins are robust at 35.8% with a profit margin of 19%, supporting earnings growth. The forward PE of 10.06 is well below the industry average of 16.48, highlighting a value tilt, while a low beta of 0.69 and 30‑day volatility of 21.9% suggest moderate price swings. The balance sheet shows ample cash ($224.9M) relative to dividend commitments, and the debt load is manageable given a debt‑to‑equity of zero in the reported metrics. Overall, the combination of undervaluation, strong earnings, and a growing dividend creates a compelling case for investors.
Given the technical momentum, attractive valuation, and sustainable dividend, a buy stance is warranted for medium‑ to long‑term horizons, while a hold recommendation is prudent in the very short term as the price tests the near‑term resistance. The low liquidity risk, stable volume, and limited geographic exposure further support a favorable risk‑adjusted profile.
Given the technical momentum, attractive valuation, and sustainable dividend, a buy stance is warranted for medium‑ to long‑term horizons, while a hold recommendation is prudent in the very short term as the price tests the near‑term resistance. The low liquidity risk, stable volume, and limited geographic exposure further support a favorable risk‑adjusted profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term resistance at $35.19
- Bullish MACD and SMA alignment
- Stable volume and moderate volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 12% upside to DCF fair value
- Revenue growth of 36% and strong margins
- Dividend increase and 3.11% yield
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Undervalued relative to forward PE and industry peers
- Sustainable dividend with payout ratio ~52%
- Low beta and solid cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth36.20%
Profit Margin19.02%
P/E Ratio16.8
ROE6.56%
ROA0.84%
P/B Ratio1.1
Op. Cash Flow$180.0M
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI57.6
Support$33.10
Resistance$35.19
MA 20$34.15
MA 50$34.74
MA 200$34.56
MACDBullish
VolumeStable
Fear & Greed Index82.7
Valuation
Fair Value$45.56
Target Price$39.25
Upside/Downside12.01%
GradeUndervalued
TypeBlend
Dividend Yield3.11%
Risk Assessment
Beta0.69
Volatility21.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.